Simon N Waddingon

  • Citations Per Year
Learn More
The development of robust nonviral vectors could facilitate clinical gene therapy applications and may overcome some of the immune complications of viral vectors. Nevertheless, most nonviral gene deliver approaches typically yield only transient and/or low gene expression. To address these caveats, we have explored piggyBac transposons to correct hemophilia(More)
Department of Gene Therapy & Regenerative Medicine, Free University of Brussels, Brussels, Belgium & Center for Molecular & Vascular Biology, Department of Cardiovascular Medicine, University of Leuven, Leuven, Belgium; Molecular Immunology Unit, Institute of Child Health, University College London, London, United Kingdom; Institute for Women’s Health Gene(More)
  • 1